Literature DB >> 15750085

CHROMagar Candida as the sole primary medium for isolation of yeasts and as a source medium for the rapid-assimilation-of-trehalose test.

Melissa P Murray1, Riva Zinchuk, Davise H Larone.   

Abstract

The chromogenic medium BBL CHROMagar Candida (CAC) was evaluated as a sole primary medium for the isolation of yeasts from clinical specimens in which yeasts are the primary concern. Additionally, the reliability of the rapid-assimilation-of-trehalose (RAT) test in yielding correct results with isolates taken from CAC was assessed. A total of 270 throat, urine, and genital (TUG) specimens were streaked onto CAC, Sabouraud dextrose agar (SDA), inhibitory mold agar (IMA), and Mycosel (MYC). A total of 69 blood culture broths that were smear positive for yeast were streaked onto CAC and SDA. A 1-h RAT test (NCCLS M35-A) was performed simultaneously on isolates from CAC and SDA. A total of 112 TUG specimens yielded yeast colonies (CAC, 111 colonies; IMA, 105; SDA, 103; MYC, 91). The 69 blood culture yeasts grew on both CAC and SDA. Mixed cultures of yeasts were detected on 11 CAC plates but were unrecognized on other media. Colonies suspected of being C. glabrata on 32 CAC plates were all RAT test positive and confirmed to be C. glabrata; of 59 colonies with various characteristics of color and morphology on CAC, none were RAT positive, and all were conventionally identified as yeasts other than C. glabrata (sensitivity and specificity, 100%). The same isolates from SDA tested for RAT produced six false negatives and no false positives (sensitivity, 81%; specificity, 100%). The results show that CAC can be used as the sole primary medium for recovery of yeasts from clinical specimens. Additionally, isolates grown on CAC yield excellent results with the RAT test utilized in this study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750085      PMCID: PMC1081275          DOI: 10.1128/JCM.43.3.1210-1212.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; S A Messer; A Houston; S Coffman; R J Hollis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium.

Authors:  Duane R Hospenthal; Clinton K Murray; Miriam L Beckius; Judith A Green; David P Dooley
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

4.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.

Authors:  M S Rangel-Frausto; T Wiblin; H M Blumberg; L Saiman; J Patterson; M Rinaldi; M Pfaller; J E Edwards; W Jarvis; J Dawson; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

5.  Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

Authors:  D J Diekema; S A Messer; A B Brueggemann; S L Coffman; G V Doern; L A Herwaldt; M A Pfaller
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999).

Authors:  Amar Safdar; Vishnu Chaturvedi; Brian S Koll; Davise H Larone; David S Perlin; Donald Armstrong
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 7.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance.

Authors:  S Bernal; E Martín Mazuelos; M García; A I Aller; M A Martínez; M J Gutiérrez
Journal:  Diagn Microbiol Infect Dis       Date:  1996-04       Impact factor: 2.803

9.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more
  6 in total

1.  Comparative study of the new colorimetric VITEK 2 yeast identification card versus the older fluorometric card and of CHROMagar Candida as a source medium with the new card.

Authors:  C L Aubertine; M Rivera; S M Rohan; D H Larone
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Biographical Feature: Davise H. Larone, Ph.D.

Authors:  Karen C Carroll
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

3.  Use of CHROMagar in the differentiation of common species of Candida.

Authors:  V G Sivakumar; P Shankar; K Nalina; Thangam Menon
Journal:  Mycopathologia       Date:  2008-08-21       Impact factor: 2.574

4.  Epidemiology of Candida kefyr in patients with hematologic malignancies.

Authors:  Simon F Dufresne; Kieren A Marr; Emily Sydnor; Janet F Staab; Judith E Karp; Kit Lu; Sean X Zhang; Christian Lavallée; Trish M Perl; Dionysios Neofytos
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

5.  Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India.

Authors:  P Bhattacharjee
Journal:  Curr Med Mycol       Date:  2016-06

6.  A comparative study to assess risk of oral candidiasis in pregnant and nonpregnant women.

Authors:  Heena Zainab; Deepa Hugar; Ameena Sultana
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.